Moleculin Secures Australian Patent for Annamycin Formulation Technology

Markets GlobeNewswire By GlobeNewswire 12 Nov 2026 13:37 1 min read
Moleculin Secures Australian Patent for Annamycin Formulation Technology

Patent strengthens intellectual property protection for preparation of preliposomal Annamycin lyophilizate

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.